{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:58:17Z","timestamp":1790899097473,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82127807"],"award-info":[{"award-number":["82127807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003142"],"award-info":[{"award-number":["82003142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52103171"],"award-info":[{"award-number":["52103171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015377","name":"Shanghai Key Laboratory of Molecular Imaging","doi-asserted-by":"publisher","award":["18DZ2260400"],"award-info":[{"award-number":["18DZ2260400"]}],"id":[{"id":"10.13039\/501100015377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2024ZZ2056"],"award-info":[{"award-number":["2024ZZ2056"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0909000"],"award-info":[{"award-number":["2020YFA0909000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23010502600"],"award-info":[{"award-number":["23010502600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cellsig.2026.112580","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:32:01Z","timestamp":1778340721000},"page":"112580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ginsenoside Rh2 from ginseng exosomes enhances chemotherapy sensitivity in non-small cell lung cancer by modulating the USP22-RRM2 axis"],"prefix":"10.1016","volume":"145","author":[{"given":"Jiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Entao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouqiutong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengfeng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112580_bb0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non\u2013small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.cellsig.2026.112580_bb0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/bph.16257","article-title":"Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer","volume":"181","author":"Gy\u0151rffy","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112580_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer","volume":"169","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112580_bb0020","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1200\/JCO.23.01891","article-title":"Phase III, randomized study of Atezolizumab plus bevacizumab and chemotherapy in patients with EGFR- or ALK-rearranged or translocated non\u2013small-cell lung cancer (ATTLAS, KCSG-LU19-04)","volume":"42","author":"Park","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112580_bb0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa2215530","article-title":"Perioperative Nivolumab and chemotherapy in stage III non\u2013small-cell lung cancer","volume":"389","author":"Provencio","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2026.112580_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112580_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105701","article-title":"Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer","volume":"170","author":"Cai","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2026.112580_bb0040","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.apsb.2018.04.005","article-title":"Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective","volume":"8","author":"Jiang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2026.112580_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117270","article-title":"Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK\/JUN\/IL-8 signaling pathway","volume":"319","author":"Jin","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cellsig.2026.112580_bb0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41419-024-07045-2","article-title":"NEK6 dampens FOXO3 nuclear translocation to stabilize C-MYC and promotes subsequent de novo purine synthesis to support ovarian cancer chemoresistance","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112580_bb0055","article-title":"Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia","author":"Wu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.cellsig.2026.112580_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112093","article-title":"Total ginsenosides extract induce autophagic cell death in NSCLC cells through activation of endoplasmic reticulum stress","volume":"243","author":"Zhao","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cellsig.2026.112580_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.eujim.2021.101368","article-title":"Aidi injection, a traditional Chinese medicine extract, reverses Gefitinib resistance in non-small cell lung cancer cells","volume":"46","author":"Biswas","year":"2021","journal-title":"Eur. J. Integr. Med."},{"key":"10.1016\/j.cellsig.2026.112580_bb0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13046-019-1120-4","article-title":"Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer","volume":"38","author":"Huang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112580_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s10020-024-00813-y","article-title":"Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-\u03b1\/PDK4 axis in non-small cell lung cancer","volume":"30","author":"Liu","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.cellsig.2026.112580_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9715154","article-title":"Ginsenoside Rh2 inhibits glycolysis through the STAT3\/c-MYC axis in non-small-cell lung cancer","volume":"2021","author":"Sun","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.cellsig.2026.112580_bb0085","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/JLB.2A0419-117R","article-title":"Ginsenoside Rh2 reverses cyclophosphamide-induced immune deficiency by regulating fatty acid metabolism","volume":"106","author":"Qian","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellsig.2026.112580_bb0090","doi-asserted-by":"crossref","first-page":"12653","DOI":"10.1002\/cam4.5960","article-title":"Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p\/STK4 axis and inactivating Wnt\/\u03b2-catenin signaling","volume":"12","author":"Ma","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.cellsig.2026.112580_bb0095","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1200\/JCO.24.00581","article-title":"Lorlatinib versus Crizotinib in patients with advanced ALK-positive non\u2013small cell lung cancer: 5-year outcomes from the phase III CROWN study","volume":"42","author":"Solomon","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112580_bb0100","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2026.112580_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.35309","article-title":"Estrogen, estrogen receptor and the tumor microenvironment of NSCLC","author":"Diao","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellsig.2026.112580_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12935-024-03347-9","article-title":"A novel prognostic signature based on smoking-associated genes for predicting prognosis and immune microenvironment in NSCLC smokers","volume":"24","author":"Li","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cellsig.2026.112580_bb0115","first-page":"630","article-title":"Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism","volume":"18","author":"Ma","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cellsig.2026.112580_bb0120","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.7984","article-title":"Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (review)","volume":"45","author":"Zhang","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2026.112580_bb0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.gendis.2022.11.022","article-title":"Ribonucleotide reductase M2 (RRM2): regulation, function and targeting strategy in human cancer","volume":"11","author":"Zuo","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.cellsig.2026.112580_bb0130","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","article-title":"Targeting UBE2T potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress","volume":"164","author":"Jiang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellsig.2026.112580_bb0135","first-page":"969","article-title":"Varions mechanisms of deubiquitinating enzyme USP22 in cancer","volume":"47","author":"Sun Yue","year":"2020","journal-title":"Cancer Res. Prev. Treatm."},{"key":"10.1016\/j.cellsig.2026.112580_bb0140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/0008-5472.CAN-19-1033","article-title":"USP22 functions as an oncogenic driver in prostate cancer by regulating cell proliferation and DNA repair","volume":"80","author":"McCann","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112580_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202405731","article-title":"Ubiquitin-specific protease 22 plays a key role in increasing extracellular vesicle secretion and regulating cell motility of lung adenocarcinoma","volume":"11","author":"Zhen","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cellsig.2026.112580_bb0150","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41418-019-0420-8","article-title":"USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity","volume":"27","author":"Kosinsky","year":"2020","journal-title":"Cell Death Differ."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826002330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826002330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:39:15Z","timestamp":1783183155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826002330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0898656826002330"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112580","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rh2 from ginseng exosomes enhances chemotherapy sensitivity in non-small cell lung cancer by modulating the USP22-RRM2 axis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112580"}}